This study is a 12-week comparison of wound care using a platelet-rich fibrin membrane (CASCADE® Autologous Platelet System) compared to the usual standard treatment for chronic non-healing wounds.
You may be eligible to participate in this study if you meet the following criteria:
Affected with diabetic foot ulcers
Affected with venous leg ulcers
Affected with pressure ulcers
Clinical Trial Investigator
Dr. Jose David Suarez, Principal Investigator